Building an AI-native pharmaceutical enterprise: Lupin’s blueprint for intelligent transformation
AI-native pharmaceutical organizations will not be defined by the number of AI models they deploy, but by their ability to create connected ecosystems where science, data, and technology converge. Rakesh Bhardwaj, Global Chief Information Officer at Lupin, explains how the company is building a future-ready digital foundation spanning data modernisation, AI-led decision-making, smart manufacturing, and a new era of technology leadership.
For decades, technology transformation in the pharmaceutical industry was largely associated with improving efficiency, automating workflows, and digitising processes. While these efforts laid a strong digital foundation, the next phase of transformation demands something far more ambitious—building intelligent enterprises where data, AI, and technology become central to every business decision.
At Lupin, this transformation is being guided by a clear vision: creating an intelligent and connected ecosystem where science, data, and technology come together to improve business outcomes and ultimately enhance patient lives.
According to Rakesh Bhardwaj, the industry...
Copyright of this story solely belongs to expresscomputer.in. To see the full text click HERE
